Recent Posts
Archives
IR Department Managing Director Jane Lowe featured in CFO magazine
IR Department Managing Director: Award Finalist
Podcast - interview with Peter Devine, CEO of Uniseed
IR Department client media highlights
Interview with Peter Devine, CEO of Uniseed
XPON CEO Matt Forman discusses Wondaris and how it integrates with Google
Kazia Therapeutics CEO Dr James Garner talks with SmallCaps about what's on the horizon
Interview with Assoc.Prof. Mathias Francois of Gertrude Biomedical
Podcast - IR Department talks to Race Oncology's CSO Dr Daniel Tillett
Our Digital Content Producer, Paul Langley, talks with Race Oncology's CSO Dr Daniel Tillett, who explains how the recent clinical trials are evolving and what it means for the future. He gives a brief overview on the history of Race, their aspirations and milestones for development and eventual commercialisation of Zantrene.
HaemaLogiX's Tertia Dex explains the KappaMab antibody
Race Oncology CSO Dr Daniel Tillett discusses the bright future for Zantrene
Mosquito-borne diseases in Australia - an interview with Dr David Foster, CEO of Island Pharmaceuticals
Podcast - IR Department talks with AdAlta CEO & MD, Dr Tim Oldham
Our Communications Director, Cherie Hartley, talks with AdAlta's CEO & M.D. Dr Tim Oldham at this year's Bioshares Biotech Summit, who takes us inside the mind of a biotech company. He discussed the importance of focus for a platform company, explains why making decisions on a day-to-day basis is so crucial for risk reduction and why they're investing in supporting core strategies as well as their target product profile.
IRD Invest March 2022 - Openpay
IRD Invest March 2022 - "Project: 2025"
Watch the replay of Openpay's CEO (Australia & New Zealand) Dion Appel.
IRD Invest March 2022 - Oventus
IRD Invest 31st March 2022 - "Project: 2025"
Watch the replay of Oventus CEO John Cox's presentation.
IRD Invest March 2022 - Pureprofile
IRD Invest 31st March 2022 - "Project: 2025"
Watch the replay of Pureprofile CEO Martin Filz's presentation.
Register now for our next IRD Invest virtual investor conference, where emerging tech companies will talk about the tailwinds driving their businesses
CEO in focus - Pureprofile's Martin Filz
UniSeed: UniSuper makes first venture capital foray with $75m funding (afr.com)
Servatus launches new trial into the effects of live biotherapeutics on insomnia
Servatus launches new trial into the effects of live biotherapeutics on insomnia, we talk to CEO Dr Wayne Finlayson to discuss this exciting initiative.
